Fighting cancer with everything we know™
We believe that knowledge is power. And in the fight versus cancer, AccessHope deploys the latest evidence-based recommendations, research, knowledge, and insights to employees and their treating oncologists across the country, regardless of their zip code.
A troubling gap exists between cancer treatment and cancer outcomes based on race, ethnicity, socioeconomic status, sexual orientation, and other characteristics.1
Read more
In today’s healthcare landscape, the focus is shifting towards addressing the rising costs associated with cancer. For organizations and health plans managing expenses, cancer has become a significant contributor to healthcare spending.
Read more
Employers across the U.S. are preparing for open enrollment seasons that run November 1 through January 15, and cancer benefits are in the spotlight. The 2023 annual survey from the Business Group on Health found that cancer spending is a leading driver of healthcare expenditures and the survey highlighted the strategic initiatives undertaken by employers.
Read more
AccessHope achieves SOC 2 Type II compliance in accordance with American Institute of Certified Public Accountants (AICPA) standards for SOC for Service Organizations—also known as SSAE 18. Achieving this standard with an unqualified opinion serves as third-party industry validation that AccessHope provides enterprise-level security for customer data secured in the AccessHope system.
Read more
Your liver is an essential organ with several critical functions, including digestion and detoxification. Much like other organs in the body, the liver is not immune to the threat of cancer. Fortunately, liver cancer is relatively rare, offering some solace in the face of this potential risk. However, it’s important to acknowledge that the number of liver cancer cases is steadily increasing.
Read more
Caregivers form a crucial support network within our healthcare system, yet generally don’t receive formal recognition or financial compensation for their efforts. That’s why we’re here to support you—the employer—in empowering your caregiving employees.
Read more
A new study, published by the Journal of Personalized Medicine, highlights AccessHope’s clinical impact on 94 cases of pancreatic adenocarcinoma (reviewed between August 2019–December 2022). The findings show that in 94% of cases, the subspecialist provided recommendations anticipated to improve outcomes. Gaps in care were more pronounced in patients with non-metastatic pancreatic cancer.
Read more
The Business Group of Health Survey is an annual survey that sheds light on the strategic initiatives undertaken by employers in addressing crucial health concerns. Within the realm of oncology, this year’s recently published survey offers a panoramic view of how employers perceive and prioritize cancer care within their benefit offerings.
Read more
AccessHope achieves HITRUST CSF® Certification. This achievement places AccessHope in an elite group of organizations worldwide that have earned this certification and enables us to serve our customers and people with cancer with the highest standard of security and privacy.
Read more
Lung cancer can be a complex disease, and oncologists are finding that the best way to fight it involves more than one treatment. While surgery is a common way to treat early-stage lung cancer, fortifying surgery with other modes of therapy can lead to the best outcomes. And that’s where perioperative therapy for early-stage lung cancer comes in.
Read more